Windlas Biotech Limited (WINDLAS) — Free Cash Flow Generation Index

Latest as of December 2023: 1.00x

Windlas Biotech Limited (WINDLAS) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Rs67.78 Million represents 1% of operating cash flow (Rs67.78 Million). See Windlas Biotech Limited (WINDLAS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

Rs67.78 Million
INR

Operating Cash Flow

Rs67.78 Million
INR

Capital Expenditures

Rs0.00
INR

Windlas Biotech Limited Free Cash Flow Generation Index (2018–2025)

Historical FCF Generation Index trend for Windlas Biotech Limited across 8 annual periods. Explore Windlas Biotech Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Windlas Biotech Limited (2018–2025)

Year-by-year Free Cash Flow Generation Index for Windlas Biotech Limited. For the full company profile including market capitalisation, see market cap of Windlas Biotech Limited.

Year FCG Index Free Cash Flow (INR) Operating CF Capital Expenditures YoY Change
2025 0.23x Rs159.93 Million Rs681.87 Million Rs521.94 Million ▼ -64.1%
2024 0.65x Rs712.76 Million Rs1.09 Billion Rs376.84 Million ▲ +501.8%
2023 -0.16x Rs-99.25 Million Rs609.65 Million Rs708.90 Million ▲ +73.8%
2022 -0.62x Rs-56.74 Million Rs91.30 Million Rs148.04 Million ▼ -227.0%
2021 0.49x Rs56.07 Million Rs114.54 Million Rs58.47 Million ▲ +26.2%
2020 0.39x Rs96.96 Million Rs250.06 Million Rs153.10 Million ▼ -25.4%
2019 0.52x Rs97.00 Million Rs186.54 Million Rs89.54 Million ▲ +304.0%
2018 0.13x Rs38.09 Million Rs295.91 Million Rs257.82 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).